Hepion Pharmaceuticals
HEPA
#10815
Rank
A$22.09 M
Marketcap
A$0.18
Share price
3.22%
Change (1 day)
65.23%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2026 (TTM): -A$11.34 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$19.73 Million, an increase over its 2024 earnings that were of -A$23.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$11.34 Million-42.52%
2025 -A$19.73 Million-16.06%
2024 -A$23.5 Million-68.5%
2023 -A$74.6 Million9.74%
2022 -A$67.98 Million37.49%
2021 -A$49.44 Million61.27%
2020 -A$30.66 Million174.55%
2019 -A$11.17 Million-31.28%
2018 -A$16.26 Million
2016 -A$32.26 Million6.03%
2015 -A$30.42 Million265%
2014 -A$8.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 1,940.94%๐Ÿ‡บ๐Ÿ‡ธ USA